Biohaven - BHVN Company Short-Term Debt

Public company logo of Biohaven (BHVN)

Biohaven Ltd. (BHVN) relies on intensive research and development in protein degradation and the treatment of epileptic seizures, preparing a series of critical publications. The biopharmaceutical business focuses on psychiatry and the BHV-7000 platform, maintaining a stable capital position, which is confirmed by the daily price chart on GURU.Markets, where the metric stands at 0.01. Growth prospects are linked to patents, the success of Kv7, and the probability of an acquisition by a tech giant.

BHVN biohavenpharma.com Company Short-Term Debt (07/04/2022 - 10/29/2026)

Summary analytical data breakdowns for Biohaven Corp (BHVN)

- price and consensus price forecast:
Price Chart Biohaven|BHVN - Fair Value Consensus
- market capitalization data:
Market Value Biohaven Ltd.|BHVN - Total Enterprise Value
- book capitalization data:
Book Value per Share Biohaven|BHVN - Company Book Value|Market Capitalization to Book Value Ratio biohavenpharma.com|BHVN - Company Total Asset Base
- debt and liquidity data:
Debt to Equity Biohaven Ltd.|BHVN - Long-Term Liabilities to Capital|Short-Term Debt to Capital Biohaven Ltd.|BHVN - Aggregate Debt Obligations|Debts to Book Capitalization Biohaven Ltd.|BHVN - Company Long-Term Debts|Company Current Liabilities Biohaven
Analysis of all company metrics:Biohaven (BHVN)
Finished products of Biohaven Corp

Biohaven Ltd. (BHVN) possesses significant market influence due to its unique developments in the therapy of neurodegenerative diseases. This indicator measures the total volume of liabilities requiring settlement within the next twelve months. Assessing current liquidity determines the issuer's ability to service debts without selling strategic assets. For the biotechnology sector, the balance between borrowed capital and R&D rates is critical. By analyzing the level of short-term loans, an investor evaluates the financial stability of the business.

Competitor analysis

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|Axsome Corp (AXSM) - Short-Term Debt|Company Short-Term Debts ACADIA Pharmaceuticals|Company Short-Term Debt xenon-pharma.com|VKTX (Viking Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Volume SUPN (Supernus Pharmaceuticals, Inc.)|CPRX: Company Short-Term Debt|Short-Term Debt Denali Corp DNLI|Company Short-Term Debts Harmony Biosciences (HRMY)|AMLX - Company Short-Term Loans and Borrowings|TRVI: Company Short-Term Debts|Company Short-Term Debts Praxis Precision Medicines Inc|Company Current Liabilities Anavex Corp|Company Short-Term Debt CeriBell EEG|Prothena - Company Short-Term Debts|Short-Term Debt ALEC (alector.com)|ANNX - Company Short-Term Debt|OMER - Company Short-Term Indebtedness|Company Current Liabilities Neurogene Corp (NGNE)|ACIU: Company Short-Term Loans and Borrowings|Voyager Therapeutics (VYGR) - Company Short-Term Debt|Company Short-Term Debt neumoratx.com|Scilex (SCLX) - Company Current Liabilities|Amount of Current Liabilities Tevogen Bio Holdings Inc.|Company Short-Term Debts Alpha Cognition ACOG|Company Short-Term Indebtedness cogrx.com CGTX|Company Current Liabilities IKT|Short-Term Debt Volume cassavasciences.com SAVA|ASRT - Company Short-Term Debts|COYA - Company Short-Term Debt|Company Short-Term Debts vistagen.com VTGN|Company Short-Term Loans and Borrowings Ovid Therapeutics|Company Current Liabilities Acumen Pharmaceuticals|Company Short-Term Debt CRVO|Company Short-Term Debt Alterity Therapeutics ATHE|Company Short-Term Indebtedness CLNN (clene.com)|PEPG - Company Short-Term Debt|Company Short-Term Indebtedness jupiterneurosciences.com JUNS|RLMD (Relmada Therapeutics) - Company Short-Term Debts|annovisbio.com (ANVS) - Short-Term Debt|GRCE: Company Current Liabilities|AIFF (Firefly Neuroscience, Inc.) - Company Short-Term Debts|KLTO - Company Short-Term Debt|Company Short-Term Loans and Borrowings NRSN|Reviva Pharmaceuticals - Company Short-Term Debt|Short-Term Debt metaviatx.com (MTVA)|Company Short-Term Debts NeurAxis NRXS|Company Short-Term Debt Helius Medical Technologies, Inc. HSDT|Company Short-Term Debts PASG (Passage Bio Corp)|NEUP: Short-Term Debt Volume|Company Short-Term Debt NERV|athira.com (ATHA) - Short-Term Debt|ADXN - Company Short-Term Debts|Company Short-Term Loans and Borrowings Alzamend|Company Short-Term Debts CYCN|Company Short-Term Debts protagenic.com PTIX|Company Current Liabilities Pasithea Therapeutics Corp. KTTA|Company Short-Term Debt Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc.) - Company Short-Term Debts|BCLI: Short-Term Debt|Company Short-Term Debt Cara Therapeutics, Inc|Company Short-Term Indebtedness Chromocell|ELYM - Company Current Liabilities|Company Short-Term Loans and Borrowings ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Company Short-Term Debt Marinus Pharmaceuticals Inc MRNS|Company Current Liabilities NKGen (NKGN)|Amount of Current Liabilities NeuroBo Pharma NRBO|Sage Therapeutics, Inc. (SAGE) - Company Short-Term Debts|synaptogen.com (SNPX) - Company Short-Term Indebtedness|Trevena - Company Current Liabilities|Vigil Neuroscience, Inc. (VIGL) - Short-Term Debt Volume|Company Short-Term Debts Anew Medical, Inc.|Company Short-Term Debt Cerevel Corp